Development of oseltamivir resistance during oseltamivir therapy in a child with severe 2009 H1N1 influenza.
Glikman
Daniel
D
Zonis
Zeev
Z
Hindiyeh
Musa
M
Hindyieh
Musa
M
Ram
Daniela
D
Mandelboim
Michal
M
Mendelson
Ella
E
Engelhard
Dan
D
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D024882:Drug Resistance, Viral / Q000235:genetics*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects*; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000821:virology; D007557:Israel; D008297:Male; D053139:Oseltamivir / Q000494:pharmacology / Q000627:therapeutic use; D011023:Pneumonia, Staphylococcal / Q000150:complications / Q000382:microbiology; D012720:Severity of Illness Index; D013211:Staphylococcus aureus; D016896:Treatment Outcome
D000998:Antiviral Agents; D053139:Oseltamivir